For the first time, scientists and clinicians have presented official clinical guidelines for the use of psychedelic medicine — directed instructions for doctors and specialists to help them safely and effectively employ psychedelic methods in the treatment of mental health disorders, reports News Medical Live Sciences.

This document is part of the expanded digital Johns Hopkins Psychiatry POC-IT Guide, which is widely used by clinicians around the world.

Psychedelic medicine is a field that studies the use of psychedelics, such as psilocybin and other psychoactive substances, in combination with psychotherapy to treat complex and treatment-resistant mental health conditions.

In recent years, these methods have been actively studied in clinical trials, and research data indicate their potential to improve outcomes for patients for whom standard approaches have been ineffective.

The new guidelines were developed by experts at the Center for Psychedelic Medicine and Consciousness Research at Johns Hopkins University, one of the largest research centers in this field.

They provide evidence-based clinical approaches to help doctors make informed decisions rather than rely on guesswork when it comes to psychedelic interventions. The goal of the guidelines is to improve treatment outcomes, reduce patient risks, and give specialists clear directions in this rapidly developing area of medicine.

The guide places particular emphasis on patient safety: it helps physicians screen patients beforehand, discuss potential risks and expected effects, and provide supervision during and after therapeutic sessions. These practices are especially important for individuals with difficult-to-treat depression, post-traumatic stress disorder (PTSD), and other complex mental health conditions for which traditional methods may have been insufficient.

The updated guide also includes educational materials for patients to improve their understanding of potential effects, as well as content aligned with DSM-5-TR criteria and updated sections on medications. The guide is already available through the Johns Hopkins Psychiatry Guide app on popular platforms such as the App Store and Google Play, as well as via institutional access.